Slate Therapeutics is the developer of a novel effervescent foam system for treating chronic sinusitis without leaving behind any implant.

The company’s product delivers nano-structured MF locally into every sinus using a dedicated delivery device during office and surgical procedures.The foam enables sustained drug delivery directly to the nasal mucosa, with or without an implant.

The foam is administered into the nasal cavity using a novel delivery system that is designed to be compatible with endoscopic and functional endoscopic sinus surgery delivery lumen and suitable for foam generation.